欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/1120/002
药品名称
Refidoro
活性成分
ezetimibe 10.0 mg
rosuvastatin calcium 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Alkaloid-Int d.o.o. Šlandrova Ulica 4 Ljubljana Slovenia 1231
参考成员国 - 产品名称
Czechia (CZ)
Refidoro
互认成员国 - 产品名称
Slovenia (SI)
Croatia (HR)
Bulgaria (BG)
Rosuvastatin/Ezetimib Alkaloid-INT
许可日期
2022/11/02
最近更新日期
2024/07/04
药物ATC编码
C10BA06 rosuvastatin and ezetimibe
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
common_labelling_Rosu_Eze_2
Date of last change:2024/09/06
Final PL
|
common_pil_Refidoro_IB_001_cl
Date of last change:2024/09/06
Final SPC
|
common_smpc_Refidoro_IB_001_cl
Date of last change:2024/09/06
PubAR
|
CZ_H_1120_001_004_DC_PAR _ ELPEN comments_Alkaloid comments fin
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase